Supartz Research

The safety and effectiveness of Supartz were observed in five clinical trials. Studies were conducted in Germany, Sweden, France, UK and Australia. 5 weekly injections of Supartz or salt water placebo were performed in one knee joint of each patient.

In the French study, there were 3 treatment groups: 5 Supartz injections per patient, 3 Supartz and 2 salt water injections per patient, or 5 salt water injections per patient.

In the result of five studies where 619 patients received Supartz and 537 received salt water, it was shown that five weekly injections of Supartz into the knee is both safe and effective in relieving pain associated with osteoarthritis of the knee that failed to respond with simple painkillers or exercise and physical therapy.